Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             201 results found
no title author magazine year volume issue page(s) type
1 Editorial Board
8 S p.
 article
2 OP 8.6 – 00166 Autologous neutralizing antibody responses in bnAb-treated rhesus macaques Bar, K.
8 S p.
 article
3 OP 2.1 CCR5 in HIV Prevention and Cure Wu, Helen L.
8 S p.
 article
4 OP 4.8 – 00149 CD8+ T cells promote hiv latency in CD4+ T cells through the downmodulation of NF-kB Mutascio, S.
8 S p.
 article
5 OP 5.2 – 00070 Characterization of a dual PTPN1/PTPN2 inhibitor to target latent HIV reservoirs Bosque, A.
8 S p.
 article
6 OP 3.8 – 00066 Characterization of the HIV-1 viral reservoir in subtype B early treated individuals Struyve, T.
8 S p.
 article
7 OP 2.2 – 00200 Characterization of the SIV tissue reservoir transcriptional environment at the single focus level during ART and post ATI Arif, M.
8 S p.
 article
8 OP 4.7 – 00121 Circulating immune predictors of intact HIV reservoir decay during long-term ART Peluso, M.
8 S p.
 article
9 OP 1.10 – 00210 Clonal Dynamics within HIV-Infected CD4 T Cell Reservoirs after PD-1 Blockade under ART Perez, L.
8 S p.
 article
10 OP 3.2 – 00056 Clonally expanded HIV-1 proviruses with 5′-Leader defects can give rise to nonsuppressible residual viremia and complicate ART management Wu, F.
8 S p.
 article
11 OP 3.7 – 00099 Cohort-specific Adaptation of the Intact Proviral DNA Assay (IPDA) to HIV-1 subtypes A1, D, and recombinants Gowanlock, S.N.
8 S p.
 article
12 OP 4.5 – 00101 Comparative single-cell transcriptome and TCR profiling of HIV infected cells in the blood and cerebrospinal fluid of PLWH before and after ART Wang, M.
8 S p.
 article
13 OP 2.6 – 00135 Constitutive NKG2A levels and timing of antiretroviral therapy initiation impact the potential role of NK cells after treatment interruption - the pVISCONTI study Chapel, A.
8 S p.
 article
14 OP 4.2 – 00085 Cytolytic CD8+ T cells infiltrate germinal centers and limit HIV replication in spontaneous controllers Collins, D.R.
8 S p.
 article
15 OP 1.4 – 00053 Definitive evidence of a persistent HIV reservoir in human brain myeloid cells despite ART Tang, Y.
8 S p.
 article
16 OP 6.3 – 00150 Delivery and long-term expression of CCR5-blocking monoclonal antibody Leronlimab with AAV for ART-free remission from SHIV viremia Webb, G.
8 S p.
 article
17 OP 3.6 – 00023 Effect of HIV-1 infection, viral particle production, and proviral integration site on CD4+ T cell proliferation Kufera, J.
8 S p.
 article
18 OP 2.8 – 00193 Enhancing PKC Modulator HIV Latency Reversing Agents Marsden, M.
8 S p.
 article
19 OP 6.4 – 00096 High-efficiency CRISPR/Cas9-mediated disruption of ccr5 in human hematopoietic stem progenitor cells generates HIV-refractory immune systems Claiborne, D.
8 S p.
 article
20 OP 3.1 HIV Persistence in women, an update Archin, N.
8 S p.
 article
21 OP 4.4 – 00018 HIV reservoir burden associates with numbers of HIV-specific CD8+ T cells under long-term antiretroviral therapy and prevents them from differentiating into functional memory cells Takata, H.
8 S p.
 article
22 OP 3.5 – 00152 HIV-1RNA+infected CD4 T cell burden in acute HIV-1 infection and association with inflammatory markers Bolton, D.
8 S p.
 article
23 OP 1.2 – 00157 HIV Silencing and Cell Survival Signatures of HIV-Infected CD4 T Cell Transcriptomes under Antiretroviral Therapy (ART) Clark, I.C.
8 S p.
 article
24 OP 8.3 – 00028 HIV-vaccine induced, broad and polyfunctional CD4 and CD8 T cell responses are associated with prolonged time off ART and lower pVL at the end of ATI in the AELIX-002 therapeutic vaccine trial Mothe, B.
8 S p.
 article
25 OP 5.4 – 00127 Identification and characterization of novel inhibitors of HIV Tat protein Jablonski, S. Mediouni
8 S p.
 article
26 OP 7.2 – 00035 Impact of 10-1074LS and 3BNC117-LS on viral rebound dynamics following treatment interruption six months after dosing: four cases from the open label arm of the RIO trial Lee, M.
8 S p.
 article
27 OP 5.5 – 00083 Impairment of HIV proviral reactivation by interfering with essential metabolic pathways in effector memory CD4+ T cells Fernández, G. Casado
8 S p.
 article
28 OP 3.3 – 00030 Inducible replication-competent HIV proviruses persist in memory CD4+ T cells expressing high levels of the integrin VLA-4 (α4β1) Dufour, C.
8 S p.
 article
29 OP 3.4 – 00197 Infected naïve CD4+ T cells in children with HIV can proliferate and persist on ART Katusiime, M.
8 S p.
 article
30 OP 8.2 – 00033 Interleukin-2 administration is a potent latency reversal agent in people with treated HIV infection Freeman, M.
8 S p.
 article
31 OP 6.8 – 00102 In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-eCD4-Ig therapy O'Hagan, D.
8 S p.
 article
32 OP 6.1 It's a mountain not a hill: Progress made in realizing AAV-delivered inhibitors for an HIV cure Gardner, Matthew R.
8 S p.
 article
33 OP 4.3 – 00112 Leaky reservoirs are associated with HIV-specific cd4 and CD8 T-cell responses Dube, M.
8 S p.
 article
34 OP 6.7 – 00044 Long-term ART-free SIV Remission Following Allogeneic Hematopoietic Cell Transplantation in Mauritian Cynomolgus Macaques Wu, H.
8 S p.
 article
35 OP 1.9 – 00042 Measuring the impact of early 3BNC117 intervention at ART initiation on the productive reservoir in a cohort of diverse viral subtypes: results from the VIP-SPOT assay in the eCLEAR trial Puertas, M.C.
8 S p.
 article
36 OP 6.5 – 00164 Nanobody-engineered AAV vectors for CD4-targeted gene therapy Lange, U.
8 S p.
 article
37 OP 4.6 – 00185 No associations between magnitudes of HIV-specific CTL responses on stable art and subsequent decay of intact proviruses or cell-associated HIV mRNA Ward, A.
8 S p.
 article
38 OP 2.4 – 00145 No Evidence of Ongoing Viral Replication in SIV-Infected Macaques on Combination Antiretroviral Therapy Initiated in the Chronic Phase of Infection Despite Elevated Residual Plasma Viral Loads Del Prete, G.Q.
8 S p.
 article
39 OP 1.7 – 00194 Potent latency reversal enables in-depth transcriptomic analysis of the translation-competent HIV-1 reservoir Pardons, M.
8 S p.
 article
40 OP 7.3 – 00139 Pre-treatment Interruption Plasma Metabolites and Glycans Correlate with Time to HIV Rebound and Reservoir Size in ACTG A5345 Giron, L.B.
8 S p.
 article
41 OP 1.5 – 00046 P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment Mori, L.
8 S p.
 article
42 OP 1.6 – 00138 Role of UHRF1 in HIV-1 transcriptional repression through epigenetic and non-epigenetic mechanisms Aït-Ammar, A.
8 S p.
 article
43 OP 1.8 – 00204 Romidepsin in combination with the BCL-2 antagonist venetoclax synergistically reduce the size of the HIV reservoir Kim, Y.
8 S p.
 article
44 OP 1.1 Sequencing HIV: Significance and Impact Palmer, S.
8 S p.
 article
45 OP 7.4 – 00012 Series of Jojo. A way to disseminate HIV Cure information in a community language Nabukenya, J.
8 S p.
 article
46 OP 6.2 – 00195 Targeted genome engineering of human t cells in vivo for HIV cure Kumar, P.
8 S p.
 article
47 OP 2.5 – 00048 Targeting the SIV reservoir with Alemtuzumab Varco-Merth, B.
8 S p.
 article
48 OP 8.5 – 00104 TGF-beta Blockade to Stop HIV White Noise: a New “Release and Kill” HIV Strategy Martinelli, E.
8 S p.
 article
49 OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs Gramatica, A.
8 S p.
 article
50 OP 1.3 – 00017 The fraction of cells with unspliced HIV RNA is not associated with plasma viremia Capoferri, A.
8 S p.
 article
51 OP 2.7 – 00057 The latency reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific CD8+ T-cells Copertino, D.C.
8 S p.
 article
52 OP 8.4 – 00165 TLR agonist and SIV mAbs administered to SIV-infected ART-suppressed macaques did not delay rebound after treatment interruption King, H.
8 S p.
 article
53 OP 4.1 Viral persistence and NK cells Müller-Trutwin, Michaela
8 S p.
 article
54 OP 6.6 – 00134 Viral Suppression in SHIV-infected Rhesus Macaques following AAVmediated Delivery of Closer-to-germline Monoclonal Antibodies Martinez-Navio, J.
8 S p.
 article
55 OP 5.3 – 00082 1-year treatment with ponatinib provides protection of CD4+T cells against HIV that is maintained at least 1 year more after treatment interruption Manzanares, M.
8 S p.
 article
56 P 4.2 – 00029 Innate Immune Correlates of Cell-Associated HIV RNA And DNA During Long-Term Suppressive ART Lau, C.-Y.
8 S p.
 article
57 PP 7.2 – 00006 Acceptability of Home-Based Blood Collection Device for Viral Load Testing in HIV Cure Trials with Analytical Treatment Interruptions Dubé, K.
8 S p.
 article
58 PP 7.4 – 00016 Acquisition of SARS-CoV-2 infection during an HIV cure study with an ATI period Mcgowan, I.
8 S p.
 article
59 PP 8.6 – 00089 Ad26/MVA Mosaic vaccine induced antibody responses with limited cross-reactivity to CRF01_AE infections Mdluli, T.
8 S p.
 article
60 PP 2.4 – 00038 Age and biological sex but not sex hormones influence IL-15 biological activity Stover, C.
8 S p.
 article
61 PP 1.35 – 00172 A histone deacetylase network regulates epigenetic reprogramming and viral silencing in HIV infected cells Peterson, J.
8 S p.
 article
62 PP 4.20 – 00025 A Metabolic Approach to Eradicate HIV brain viral reservoirs Valdebenito-Silva, S.
8 S p.
 article
63 PP 8.8 – 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies De Taeye, S.
8 S p.
 article
64 PP 4.14 – 00173 Antiretroviral therapy repairs CD4 T cell dysregulation in people living with HIV Sponaugle, A.
8 S p.
 article
65 PP 3.15 – 00207 A polyvalent HIV-1 virus-like particle formulation drives the majority of the infectious HIV-1 reservoir out of latency within CD4+ T cells of individuals receiving cART during chronic infection Arts, E.
8 S p.
 article
66 PP 4.11 – 00126 Autologous Neutralizing Antibodies Increase with Early Antiretroviral Therapy and Shape HIV Rebound after Treatment Interruption Esmaeilzadeh, E.
8 S p.
 article
67 PP 1.24 – 00132 BET PROTACS Reveal BRD4 Disruption of the 7SK/P-TEFb Equilibrium is Critical for Effective Reactivation of Latent HIV in CD4+ T-cells Turner, A-M.
8 S p.
 article
68 PP 8.4 – 00061 Bispecific antibodies promote natural killer cell-mediated elimination of the HIV reservoir Board, N.
8 S p.
 article
69 PP 1.40 – 00074 Blood Brain Barrier Pericytes and the Molecular Impact of Active and Latent HIV Infection Naranjo, O.
8 S p.
 article
70 PP 6.2 – 00106 CAR/CXCR5 T cells contact HIV vRNA+ cells in HIV-infected humanized DRAGA mice Pumtang-On, P.
8 S p.
 article
71 PP 2.3 – 00034 CD8+ T-Cell Sieving During SIV Reactivation from Latency Docken, S.
8 S p.
 article
72 PP 1.32 – 00163 cGAS/STING Signaling Drives HIV-1 Replication in Acutely Infected Macrophages Hanley, T.
8 S p.
 article
73 PP 7.5 – 00032 Changes to microglial genome structure and function in the HIV infected brain Plaza-Jennings, A.L.
8 S p.
 article
74 PP 1.38 – 00212 Characterization of SIV infected mast cells in early foci of rebound after ATI and HIV infection of primary mast cells in tissue culture models reveals an important new player in viral persistence and pathogenesis Hope, T.
8 S p.
 article
75 PP 3.8 – 00137 Characterization of the HIV-1 subtype C reservoir during ART in South-African men and women Buchholtz, N.
8 S p.
 article
76 PP 5.3 – 00115 Chemical inhibition of DPP9 sensitizes CARD8 inflammasomes in HIV-1-infected cells Clark, K.
8 S p.
 article
77 PP 1.31 – 00161 Chimeric proviral/human transcription events at the BACH2 integration locus in cellular models for chronic HIV infection Lange, U.
8 S p.
 article
78 PP 5.6 – 00183 Combination of traditional medicine product (SDK-2) with TNF-α synergistically reactivate latent HIV-1 subtype C in vitro Mngomezulu, K.
8 S p.
 article
79 PP 7.1 – 00004 Community HIV clinicians’ perceptions about HIV cure-related research in the Northwestern USA Louella, M.
8 S p.
 article
80 PP 6.4 – 00203 Construct a series of universal gRNAs targeting various regions within HIV Chen, C.
8 S p.
 article
81 PP 6.6 – 00208 Construct a series of universal gRNAs targeting various regions within HIV Chen, C.
8 S p.
 article
82 PP 1.7 – 00051 Continuous decline of intact proviral DNA after two decades of antiretroviral therapy Nühn, M.
8 S p.
 article
83 PP 1.13 – 00078 CTL epitopes from structurally important hiv proteins are identified in rebound HIV Lee, E.
8 S p.
 article
84 PP 1.25 – 00136 Daily Variations in Residual Viral Transcription in ART-Treated People Living with HIV-1 Fert, A.
8 S p.
 article
85 PP 1.30 – 00159 Dating HIV-1 reservoir formation in ARV-suppressed Ugandans Kankaka, E.N.
8 S p.
 article
86 PP 3.1 – 00058 Development of a digital PCR assay to profile HIV expression at single-infected-cell resolution Dragoni, F.
8 S p.
 article
87 PP 1.14 – 00094 Development of an immunocytochemistry assay to quantify the translationally active HIV reservoir Wu, G.
8 S p.
 article
88 PP 2.16 – 00177 Development of a nonhuman primate model to study the immunological effects of feminizing hormone therapy in transgender women Hahn, P.
8 S p.
 article
89 PP 1.19 – 00109 Differential decay dynamics of the inducible pool of HIV-1 infected CD4+ T cells and proviral DNA upon ART initiation revealed by the novel VIP-SPOT assay Puertas, M.C.
8 S p.
 article
90 PP 3.2 – 00068 Differential transcriptional levels of HIV-1 near full-length and highly deleted proviruses Nguyen, T.
8 S p.
 article
91 PP 4.5 – 00064 Differentiation Enhances Reactivation of Latent HIV-1 Reservoir in CD4+ T Cells in PLWH With > 4 Years of Viral Suppression Kuzmichev, Y.
8 S p.
 article
92 PP 8.11 – 00174 Distinct HIV reservoir characteristics among individuals treated during primary versus chronic HIV infection Oliva, C. Bittar
8 S p.
 article
93 PP 3.12 – 00180 Distinct HIV-1 resistance profiles against bNAb in intact vs defective viral genomes Giorgi, E.E.
8 S p.
 article
94 PP 4.15 – 00181 Distinctive cytoskeletal properties are implicated in the resistance of a fraction of productively HIV-infected CD4+ T-cells to killing by cytotoxic T lymphocytes (CTL) Leyre, L.
8 S p.
 article
95 PP 4.18 – 00213 Dynamics and antiviral role of TOX+ TCF1+ CD39+ CD8 T cells in lymphoid tissue of SIV-infected rhesus macaques Strongin, Z.
8 S p.
 article
96 PP 7.13 – 00090 Early evolution of HIV-1 from transmitted founders during acute infection Boltz, V.
8 S p.
 article
97 PP 2.12 – 00153 eCD4-Ig-DNA Decreased HIV Reservoir and Delayed Viral Rebound Through Fc Mediated Functions in BLT Humanized Mice Yuan, Z.
8 S p.
 article
98 PP 1.36 – 00182 Effect of HIV-1C Transmitted/Founder Viruses 5′LTRand tat Genetic Variation on Viral Reservoir Size and Latency Reversal Potential Maikoo, Shreyal
8 S p.
 article
99 PP 2.14 – 00162 Elucidating the effects of combination therapy with Venetoclax and IAP inhibitor AZD5582 in SIV-infected, ART-suppressed macaques Ukhueduan, B.
8 S p.
 article
100 PP 4.12 – 00141 Enhancement of IL15/IL15RA signaling in immune cells using CRISPR-dCas9-VPR platform Brancazio, S.
8 S p.
 article
101 PP 2.13 – 00160 Enhancing Tolerability and Efficacy of Latency Reversing Agents in “Kick and Kill” HIV Cure Approaches Moran, J.
8 S p.
 article
102 PP 3.20 – 00154 Epigenetic modifying compounds negatively impact viral replication within primary human macrophages Lê-Bury, G.
8 S p.
 article
103 PP 1.43 – 00206 Evaluating integrated HIV-1 quasispecies using Near Full Length sequencing in ART-suppressed individuals in the Drexel CARES Cohort Collins, M.
8 S p.
 article
104 PP 2.2 – 00024 Evaluation of an NNRTI-mediated Targeted Activated Cell Kill (TACK) in a Viremic Mouse Model Maxwell, J.
8 S p.
 article
105 PP 8.10 – 00155 Evaluation of HIV-specific T cell response in BEAT2 clinical trial Pampena, M.
8 S p.
 article
106 PP 3.14 – 00190 Ex vivo response to latency reversal agents of CD4+ T cell subsets and monocyte derived HIV-1 subtype C LTR from individuals on suppressive cART Gopee, K.
8 S p.
 article
107 PP 8.5 – 00080 Fc-engineering of anti-HIV-1 antibodies and nanobodies to improve Fc mediated effector functions Schriek, A.
8 S p.
 article
108 PP 1.42 – 00114 Functional Polarization of Human Monocyte-Derived Macrophage into M1-Proinflammatory Cells Restricts Both HIV-1 and Zika Virus Replication Poli, G.
8 S p.
 article
109 PP 3.17 – 00211 Genetic Diversity of HIV-1 Long Terminal Repeat in Proviral Populations During Long-Term Antiretroviral Therapy Nguyen, T.
8 S p.
 article
110 PP 3.7 – 00128 Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes Madlala, P.
8 S p.
 article
111 PP 3.6 – 00122 Heterogeneous associations between HIV genomic integrity and proviral longevity during long-term ART Brumme, Z.
8 S p.
 article
112 PP 1.4 – 00037 Histone decrotonylation uniquely regulates HIV-1 transcription and can be modulated to control HIV-1 latency Simermeyer, T.L.
8 S p.
 article
113 PP 7.9 – 00073 HIV-1 Cell-Associated RNA Provides 0.8 Prediction Accuracy for Time to Rebound after Treatment Interruption Huie, Janet
8 S p.
 article
114 PP 3.4 – 00079 HIV-1 clade C reservoir characteristics in early and chronic treated infection Reddy, K.
8 S p.
 article
115 PP 3.13 – 00189 HIV-1-infected individuals with extremely low reservoir under ART are characterized by reduced viral diversity and higher levels of hypermutations in their viral reservoirs Lorenzo-Redondo, R.
8 S p.
 article
116 PP 2.5 – 00041 HIV persistence and latency in microglia: Single-cell transcriptome analysis of three humanized mice models of HAND shows viral responses to inflammatory signaling Leskov, K.
8 S p.
 article
117 PP 4.24 – 00176 Impact of cannabis use on immune cell populations and the viral reservoir in HIV-infected people on suppressive antiretroviral therapy Falcinelli, Shane D.
8 S p.
 article
118 PP 2.1 – 00014 Impact of early antiretroviral therapy on tissue resident myeloid cells in the liver and lung of SIV-infected rhesus macaques Clain, J.
8 S p.
 article
119 PP 5.1 – 00045 Impact of Intrinsic and Extrinsic Factors on the Pharmacokinetics of Long-Acting Lenacapavir for Treatment of HIV Shaik, N.
8 S p.
 article
120 PP 2.9 – 00125 Impact of latency reversal agents on estrogen receptor alpha gene and protein expression Ceriani, C.
8 S p.
 article
121 PP 4.19 – 00021 Impact of SARS-COV-2-Mediated CD4 T Cell Activation HIV DNA Persistence In Vivo Deveau, T.-M.
8 S p.
 article
122 PP 3.9 – 00146 Impact of time on antiretroviral therapy on the proviral reservoir in people living with HIV Rutsaert, S.
8 S p.
 article
123 PP 4.23 – 00148 Inhibition of the GSK3 pathway enhances CD8+ T cell stemness and functional capacities without promoting non-cytolytic suppression of HIV transcription Statzu, M.
8 S p.
 article
124 PP 1.33 – 00167 Integrated single-cell multi-omic profiling of HIV latency reversal Manickam, A.
8 S p.
 article
125 PP 1.8 – 00054 Integrative epigenomic and transcriptomic analysis reveals distinct regulations of mRNAs and lncRNAs in active versus latent HIV-1 infection of T cells Boliar, S.
8 S p.
 article
126 PP 1.34 – 00170 Intestinal endothelial cells substantially increase HIV infection and latency in resting and activated CD4+ T cells, particularly affecting CCR6+ Th17 subpopulation Eddy, J.
8 S p.
 article
127 PP 4.3 – 00052 Intra- and extracellular levels of acyl-coA-binding protein and anti-HIV T-cell function in people living with HIV Isnard, S.
8 S p.
 article
128 PP 1.37 – 00186 Investigating Short-Term Effects of COVID-19 mRNA Vaccination on Plasma Viremia and Intact HIV Reservoir Size in Individuals Receiving Antiretroviral Therapy (ART) Duncan, M.C.
8 S p.
 article
129 PP 8.13 – 00191 Investigating the Impact of CD4 mimetic BNM-III-170 on SHIV-infected Rhesus Macaques Viox, E.
8 S p.
 article
130 PP 4.16 – 00188 Investigating the Role of Naïve CD4+ T-cells as a CTL Resistant Sanctuary for Intact HIV Proviruses Weiler, J.
8 S p.
 article
131 PP 8.12 – 00179 In Vitro Assay for Escape Pathways from Broadly Neutralizing Antibodies Murphy, T.
8 S p.
 article
132 PP 7.11 – 00091 In vivo and in vitro imaging of viral reservoirs to understand bystander damage during chronic HIV infection Eugenin, E.
8 S p.
 article
133 PP 1.10 – 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir Howard, J.
8 S p.
 article
134 PP 1.6 – 00047LAIR-1 is a negative regulator of SIV-specific CD8 T cells during chronic SIV infection Velu, V.
8 S p.
 article
135 PP 1.44 – 00107 Longitudinal evaluation of epigenetic age among people living with HIV (PLWH) undergoing multimodal curative interventions Corley, M.
8 S p.
 article
136 PP 3.3 – 00071 Longitudinal proviral landscape and reservoir dynamics in a unique case of HIV superinfection Omondi, F. Harrison
8 S p.
 article
137 PP 1.9 – 00067 Longitudinal quantification of HIV proviral DNA and host APOBEC3G/-F mRNA expression in cellular subsets that are targeted by HIV-1 Reddy, N.
8 S p.
 article
138 PP 1.23 – 00130 Long-read sequencing assay allows accurate characterization of the HIV-1 reservoir Lambrechts, L.
8 S p.
 article
139 PP 1.18 – 00105 Machine learning identifies differentiating physicochemical signatures between HIV subtypes in Nef domains associated with host-cell regulation Lamers, S.
8 S p.
 article
140 PP 2.15 – 00169 Macrophages are the primary source of virus in semen and male genital tract organs in acutely and chronically infected rhesus macaques Deleage, C.
8 S p.
 article
141 PP 7.10 – 00088 Macrophage-Tropic HIV-1 Variants Contribute to Pediatric Rebound Viremia off ART Ganta, K.
8 S p.
 article
142 PP 1.5 – 00040 Mapping of genetic interaction networks identifies a nucleosomal modification complex for silencing HIV Li, Z.
8 S p.
 article
143 PP 2.7 – 00093 Modeling HIV-1 Pathogenesis and Latency in iPSC-Derived Human Cerebral Organoids Crater, J.
8 S p.
 article
144 PP 4.10 – 00119 Multiomic dynamics of the cellular HIV reservoir after rebound during ATI Wu, V.
8 S p.
 article
145 PP 2.17 – 00187 Myeloid-derived extracellular vesicle production is upregulated with SHIV.D infection Podgorski, R.
8 S p.
 article
146 PP 5.4 – 00184 Optimization of Smac Mimetics as HIV-1 Latency Reversing Agents Pache, L.
8 S p.
 article
147 PP 8.1 – 00003 Optimization of the 5′ cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART Omange, W.
8 S p.
 article
148 PP 4.17 – 00198 Peripheral Blood Biomarkers of Occult Infection in ART-Suppressed, SIV-Infected Rhesus Macaques Boudries, M.
8 S p.
 article
149 PP 4.8 – 00108 Presentation of cognate antigens by dendritic cells causes stochastic HIV expression Moskovljevic, M.
8 S p.
 article
150 PP 2.6 – 00043 Probing cell death pathways in response to NNRTI treatment using a THP-1 infection model Zuck, P.
8 S p.
 article
151 PP 3.16 – 00209 Prolonged persistence of HIV-infected cells in tissues after allogeneic hematopoietic transplant Maldarelli, F.
8 S p.
 article
152 PP 1.15 – 00095 Proviruses persisting during the initial years of suppressive ART are relatively stable in terms of genetic diversity, clonal composition, and inferred integration date distribution Shahid, A.
8 S p.
 article
153 PP 4.4 – 00059 Quantification of HIV Reservoirs in Brain: focus in bystander damage Hernandez, C.
8 S p.
 article
154 PP 8.3 – 00049 Reduction in Markers of HIV Persistence with Gag/Pol/Il-12 DNA Therapeutic Vaccination Chew, K.
8 S p.
 article
155 PP 1.21 – 00118 Regulation of HIV-1 persistence by the CARD8 inflammasome Shan, L.
8 S p.
 article
156 PP 8.2 – 00015 Retargeting cytomegalovirus-specific CD8+ cytotoxic T lymphocytes to kill HIV/SIV-infected cells via peptide-MHC Iantibody fusion proteins Rosen, B.C.
8 S p.
 article
157 PP 4.6 – 00065 Retinoic Acid Transcriptionally Reprograms Macrophages for Increased Permissiveness to HIV-1 Replication Dias, J.
8 S p.
 article
158 PP 4.22 – 00087 Reversal of exhaustion of HIV-1-specific CTLs by CRISPR-mediated disruption of PD-1 gene Baez, C.
8 S p.
 article
159 PP 1.27 – 00147 Role of the pol gene enhancer in HIV-1 transcription and replication in myeloid infected cells Van Lint, C.
8 S p.
 article
160 PP 3.18 – 00027 Role of Tunneling Nanotubes-like Structures during the Early Events of HIV Infection and viral reactivation Valdebenito-Silva, S.
8 S p.
 article
161 PP 8.9 – 00142 Safety and activity of BCL-2 inhibitor Venetoclax in uninfected rhesus macaques Salinas, T. Wiche
8 S p.
 article
162 PP 4.21 – 00050 Seeding of long-lived HIV cellular reservoirs through differentiation of infected CCR5+CD4+ T cells into central memory cells Gao, H.
8 S p.
 article
163 PP 1.11 – 00075 Selective nuclear retention of spliced and unspliced HIV-1 mRNAs following latency reversal Honeycutt, E.
8 S p.
 article
164 PP 1.3 – 00022 Signaling pathways that activate P-TEFb to reverse HIV latency in CD4+ T cells Mbonye, U.
8 S p.
 article
165 PP 4.7 – 00097 Signatures of HIV-Infected CD4+ T Cell Resistance to NK Cell-Mediated Cytotoxicity Grasberger, P.
8 S p.
 article
166 PP 5.2 – 00072 Simulations for Once Weekly Dosing of Oral Lenacapavir Shaik, N.
8 S p.
 article
167 PP 1.16 – 00100 Single-cell multiomics analysis reveals distinct mechanisms of HIV persistence in memory CD4+ T cell subsets from tissues Frouard, J.
8 S p.
 article
168 PP 6.1 – 00005 Single cell quantification of hiv-1 and lentiviral vector in gene therapy studies Buck, A.
8 S p.
 article
169 PP 4.27 – 00202 Single-cell RNA sequencing reveals CBD genetic signature in monocyte gene expression Marini, S.
8 S p.
 article
170 PP 7.6 – 00036 Single cell transcriptomics identifies PTMA as a host gene that inhibits HIV during acute infection in vivo Geretz, A.
8 S p.
 article
171 PP 7.8 – 00060 Slowing or Reversal of Decay of Intact Proviruses Over Two Decades of Suppressive ART Cyktor, J.
8 S p.
 article
172 PP 4.13 – 00151 Soluble Factors Drive Naïve CD4+ T Cells to Differentiate into CCR5 + Tissue Resident Memory Cells that are Highly Susceptible to HIV infection Cicala, C.
8 S p.
 article
173 PP 1.41 – 00092 Spatial Transcriptomics and the Search for the Latent HIV-1 Cell Niche Dunn, D.
8 S p.
 article
174 PP 2.8 – 00124 Spironolactone Represses HIV-1 Driven Transcription in Human Microglia and T cell Models of Latency and Alters DNA Methylation of Metabolic Genes Pang, A.
8 S p.
 article
175 PP 1.2 – 00011 Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar zone supportive of early transcription reactivation Kizito, F.
8 S p.
 article
176 PP 4.26 – 00201 Study of reservoir size and telomere length in children with perinatal HIV-1 infection who achieved late viral suppression López, N.
8 S p.
 article
177 PP 1.22 – 00120 Suppression of CD4+ T-cell-intrinsic immunity by HIV-1 latency-reversing HDACi Kazmierski, J.
8 S p.
 article
178 PP 5.5 – 00026 Targeting Tat/TAR interactions with the superelongation complex for the development of novel treatments for HIV/AIDS Schulze-Gahmen, U.
8 S p.
 article
179 PP 6.3 – 00178 Targeting the human and macaque CCR5 genes using the CRISPR-SaCas9 gene-editing platform Caocci, M.
8 S p.
 article
180 PP 1.1 – 00009 TB-associated microenvironment promotes HIV latency in CD4+ T cells Duette, G.
8 S p.
 article
181 PP 7.7 – 00055 Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to a Dolutegravir-based antiretroviral regiment Ferreira, R.-C.
8 S p.
 article
182 PP 1.29 – 00158 The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb/RNAPII/TAR complex promoting HIV transcription elongation Li, C.
8 S p.
 article
183 PP 3.11 – 00171 The chromatin insulator CTCF inhibits HIV gene expression Burgos, S.
8 S p.
 article
184 PP 1.28 – 00156 The HIV-1 antisense RNA Ast promotes viral latency via epigenetic silencing of the proviral 5′LTR and is expressed in latently infected cells from ART-suppressed donors Romerio, F.
8 S p.
 article
185 PP 7.12 – 00192 The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection Sykulev, Y.
8 S p.
 article
186 PP 1.39 – 00086 The level of cell activation is associated with the pre-integrative latency of HIV linear DNA Roux, H.M.
8 S p.
 article
187 PP 1.12 – 00076 The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11 Boehm, D.
8 S p.
 article
188 PP 3.5 – 00110 The proviral quasispecies of HIV-1 Telesnitsky, A.
8 S p.
 article
189 PP 4.25 – 00196 The Role of Epigenetics in Mediating Neuronal Circuitry and Maladaptive Neuronal Changes in HIV and Opioid Drug Addiction Owens, F.
8 S p.
 article
190 PP 3.19 – 00062 The Role of Pannexin-1 channels in HIV infection and persistence Hernandez, C.
8 S p.
 article
191 PP 8.7 – 00098 The sequestration and expansion of effector lymphocytes in lymphoid tissue using combination FTY720 and N-803 immunotherapy at ART initiation fails to limit SIV persistence Harper, J.
8 S p.
 article
192 PP 1.17 – 00103 The Ubiquitin Ligase ITCH and CPSF6 Control HIV Transcription Planelles, V.
8 S p.
 article
193 PP 2.11 – 00144 Transcriptional and translational SIV profiles of peripheral and lymphoid CD4+ T cells of viremic and ART-suppressed Rhesus macaques Nayrac, M.
8 S p.
 article
194 PP 4.9 – 00113 Transcription of Defective HIV Proviruses Trigger Innate Immune Responses Kilroy, J.
8 S p.
 article
195 PP 1.26 – 00143 Understanding HIV transcription in Kaposi's sarcoma tumors during antiretroviral therapy Nolan, D.
8 S p.
 article
196 PP 6.5 – 00205 Utilization of high-throughput assays and deep-learning for selection of CRISPR/Cas9-gRNA pairs used in an HIV-1 cure strategy Berman, R.
8 S p.
 article
197 PP 4.1 – 00013 Vaccine-mediated induction of elite control-associated CD8+ cytotoxic T lymphocytes in Mamu-B*08+ Indian rhesus macaques does not protect against intrarectal SIVmac239 acquisition Rosen, B.C.
8 S p.
 article
198 PP 7.3 – 00010 Virion Immunocapture Reveals Low-level Myeloid-derived HIV Expression in Semen under INSTI-based Therapy is Disparate from Circulating Seminal and Blood Proviral Sequences Johnson, J.
8 S p.
 article
199 PP 3.10 – 00168 Vpr synergizes with vorinostat to prevent HIV-1 latency establishment Lewis, C.
8 S p.
 article
200 Table of Contents
8 S p.
 article
201 Title Page
8 S p.
 article
                             201 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands